Leisure Capital Management Has $822000 Holdings in Aerie Pharmaceuticals, Inc. (AERI)

Marco Green
November 14, 2017

One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have assigned a buy rating to the company's stock. The Dafna Capital Management Llc holds 106,770 shares with $5.61 million value, up from 46,770 last quarter. Wfg Advisors Lp who had been investing in Cerner Corp for a number of months, seems to be less bullish one the $21.71 billion market cap company.

About 306,946 shares traded. It has outperformed by 2.84% the S&P500. Castleark Management LLC now owns 77,538 shares of the company's stock worth $4,075,000 after acquiring an additional 19,648 shares during the period. Finally, Cowen and Company reaffirmed a "buy" rating on shares of Aerie Pharmaceuticals in a report on Thursday, October 5th.

Jim Tanenbaum increased its stake in Aerie Pharmaceuticals Inc.

Leisure Capital Management lowered its position in shares of Aerie Pharmaceuticals, Inc. It has outperformed by 163.50% the S&P500.

Venbio Select Advisor Llc increased Dermira Inc (NASDAQ:DERM) stake by 122,687 shares to 1.33 million valued at $38.61 million in 2017Q2. (NASDAQ:CONE) stake by 10,356 shares and now owns 41,004 shares.

Since May 26, 2017, it had 0 insider purchases, and 1 sale for $1.12 million activity. Dillman Linda M sold 4,600 shares worth $297,574. Vetr downgraded the shares of GE in report on Tuesday, September 22 to "Hold" rating. Its down 0.03, from 0.82 in 2017Q1. Raymond James & Assoc invested in 57,841 shares. 111 funds opened positions while 598 raised stakes. 254.64 million shares or 2.84% less from 262.07 million shares in 2017Q1 were reported. D L Carlson Investment Group Inc acquired 16,677 shares as General Electric (GE)'s stock declined 7.64%. Mirae Asset Com holds 0.01% or 12,257 shares. Dekabank Deutsche Girozentrale stated it has 15,900 shares. Hartford Finance Mgmt Inc has 0.02% invested in Cerner Corporation (NASDAQ:CERN). Diamond Hill holds 0% or 10,448 shares in its portfolio. Driehaus Llc, a Illinois-based fund reported 100,285 shares. Colony Gru Limited Company holds 0.02% or 5,370 shares in its portfolio. Advisor Ptnrs Ltd Co reported 3,478 shares. 414 are held by Envestnet Asset Mngmt. Partner Inv Ltd Partnership stated it has 32,496 shares. Creative Planning accumulated 3,600 shares or 0% of the stock. CERN's profit will be $196.12 million for 27.67 P/E if the $0.59 EPS becomes a reality. Bank of America downgraded it to "Neutral" rating and $31 target in Wednesday, April 26 report.

Among 14 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 14 have Buy rating, 0 Sell and 0 Hold. The company has a consensus rating of "Buy" and an average price target of $70.93. Barclays Capital has "Equal Weight" rating and $52 target. They issued a "buy" rating and a $80.00 target price for the company. (AERI) Has Jumped To A New High On FDA News" published on October 11, 2017 as well as Seekingalpha.com's news article titled: "This Might Be The Best Time To Pick Up Aerie Pharmaceuticals In 2017" with publication date: "October 23, 2017. Legal General Public Limited Company holds 7,534 shares or 0% of its portfolio. Guggenheim began coverage on Aerie Pharmaceuticals in a report on Monday, October 23rd. The firm has "Overweight" rating given on Friday, January 20 by KeyBanc Capital Markets. JMP Securities initiated the stock with "Market Outperform" rating in Wednesday, September 9 report. On Friday, September 15 the stock rating was maintained by Needham with "Buy". The company was maintained on Wednesday, September 20 by Canaccord Genuity. Canaccord Genuity has "Buy" rating and $50 target. The firm has "Buy" rating given on Thursday, October 6 by Stifel Nicolaus. The company was maintained on Monday, October 16 by Canaccord Genuity. The company was maintained on Thursday, July 20 by H.C. Wainwright.

Investors sentiment increased to 1.17 in Q2 2017. It improved, as 21 investors sold Aerie Pharmaceuticals Inc shares while 48 reduced holdings.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company.

Aerie Pharmaceuticals, Inc is a clinical-stage pharmaceutical company. Aerie Pharmaceuticals earned a media sentiment score of 0.26 on Accern's scale. Royal National Bank Of Canada owns 77,462 shares or 0% of their United States portfolio. Lipe Dalton has 0.14% invested in General Electric Company (NYSE:GE) for 7,867 shares. Adage Ptnrs Ltd Liability reported 0.44% stake. Swiss Savings Bank invested in 46,800 shares or 0% of the stock. Prelude Cap Management Limited Liability owns 14,803 shares. The legal version of this article can be read at https://www.truebluetribune.com/2017/11/12/leisure-capital-management-has-822000-stake-in-aerie-pharmaceuticals-inc-aeri.html. Advisory Inc stated it has 0.01% of its portfolio in Aerie Pharmaceuticals Inc (NASDAQ:AERI). The Florida-based Voloridge Mngmt Ltd Limited Liability Company has invested 0.1% in Aerie Pharmaceuticals Inc (NASDAQ:AERI). Waddell Reed invested in 192,100 shares or 0.02% of the stock. The stock of Aerie Pharmaceuticals Inc (NASDAQ:AERI) has "Buy" rating given on Tuesday, August 1 by Canaccord Genuity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article